Mitogenic inhibition and effect on survival of mice bearing L1210 leukemia using a combination of dehydroascorbic acid and hydroxycobalamin
- 1 June 1985
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Clinical Oncology
- Vol. 8 (3) , 266-269
- https://doi.org/10.1097/00000421-198506000-00013
Abstract
THE PRESENT STUDY WAS DESIGNED to test the effect of a combination of dehydroascorbic acid (DHA) and hydroxycobalamin (vitamin B12) on the survival of mice bearing L1210 leukemia. Results showed a significant increase in survival of treated mice compared with controls (p ≤ 0.0001) (Student's t-test). This positive effect was significantly lost when DHA was substituted by ascorbic acid (AA) in the same experimental conditions. In vitro findings also revealed that the DHA-B12 combination specifically inhibited mitoses of L1210 cells while non-neoplastic L929 cells were not affected.This publication has 6 references indexed in Scilit:
- Ascorbate-quinone interactions: electrochemical, free radical, and cytotoxic properties.Proceedings of the National Academy of Sciences, 1983
- Influence of Vitamins C and B12 on the Survival Rate of Mice Bearing Ascites TumorPathobiology, 1982
- GROWTH SUPPRESSION OF HUMAN-LEUKEMIC CELLS-INVITRO BY L-ASCORBIC-ACID1980
- Uptake of L-ascorbic acid and L-dehydroascorbic acid by human erythrocytes and HeLa cells.Journal of Nutritional Science and Vitaminology, 1979
- Inhibiting Effect of Vitamins C and B12 on the Mitotic Activity of Ascites TumorsPathobiology, 1979
- Experimental Study of the Relationship between Vitamin B12 and two Animal Tumour SystemsBritish Journal of Cancer, 1963